Léane Legrand
Graduate Intern, January 2026 - Present
I am working on the mechanisms of disease progression in mantle cell lymphoma patients treated with the AVO combination therapy. I aim to determine whether these patients have an impaired immune response due to ineffective antigen presentation. To investigate this, I will use CRISPR–Cas9 gene editing and ex vivo culture.
Outside of work, I enjoy traveling, reading, staying active through sports such as running, swimming, and climbing, and meeting new people.
